Cuprina Holdings (Cayman) LTD Logo

Cuprina Holdings (Cayman) LTD

Biomedical firm specializing in Maggot Debridement Therapy for wound care in Singapore & Hong Kong.

CUPR | US

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
United States of America
Address:
BLOCK 1090, 169201 SINGAPORE
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Cuprina Holdings is a biomedical and biotechnology company specializing in the development and commercialization of innovative wound care solutions and cosmeceuticals. The company's primary focus is on Maggot Debridement Therapy (MDT), a biotherapy for chronic wounds like diabetic foot ulcers. Its flagship product, MEDIFLY, uses medical-grade sterile larvae for the non-surgical removal of necrotic tissue, offering a clinically-proven alternative to conventional treatments with demonstrated higher healing rates and faster debridement. The company's portfolio also includes collagen-based wound care products and a range of skin restoration balms and athletic care products. Cuprina primarily serves healthcare providers and patients in Singapore and Hong Kong.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Cuprina Holdings (Cayman) LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Cuprina Holdings (Cayman) LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Cuprina Holdings (Cayman) LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Quantum Genomics Logo
Biopharma developing cardiovascular treatments, now in judicial liquidation.
France ALQGC
QuidelOrtho Corp Logo
Manufactures in-vitro diagnostic tests for at-home, point-of-care, and clinical lab settings.
United States of America QDEL
Quince Therapeutics, Inc. Logo
Late-stage biotech developing red blood cell-encapsulated drugs for rare diseases.
United States of America QNCX
Quoin Pharmaceuticals, Ltd. Logo
Clinical-stage pharma developing therapies for rare and orphan diseases like Netherton Syndrome.
United States of America QNRX
Quratis Inc. Logo
Develops infectious disease vaccines and offers biologics CDMO services for global health.
South Korea 348080
Radiopharm Theranostics Ltd Logo
Developing first-in-class radiopharmaceuticals for the diagnosis and treatment of cancer.
United States of America RADX
Rallybio Corp Logo
Develops therapies for severe and rare diseases in hematology and complement dysregulation.
United States of America RLYB
Rani Therapeutics Holdings, Inc. Logo
Develops a capsule to convert injectable biologics into oral pills for chronic diseases.
United States of America RANI
Rapport Therapeutics, Inc. Logo
Developing precision small molecule medicines for Central Nervous System (CNS) disorders.
United States of America RAPP
RAPT Therapeutics, Inc. Logo
Developing immune-targeting therapies for inflammatory and immunologic diseases.
United States of America RAPT

Talk to a Data Expert

Have a question? We'll get back to you promptly.